These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 23075530

  • 41. [Coexistence of Takayasu's arteritis and inflammatory colitis detected by fluorodeoxyglucose positron emission tomography].
    Horai Y, Kurushima S, Igawa T, Ichinose K, Nakamura H, Kawakami A.
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(5):387-390. PubMed ID: 29238022
    [Abstract] [Full Text] [Related]

  • 42. Use of 18F-fluorodeoxyglucose positron emission tomography to standardize clinical trial recruitment in Takayasu's arteritis.
    Quinn KA, Alessi HD, Ponte C, Rose E, Ahlman MA, Redmond C, Luo Y, Bolek EC, Langford CA, Merkel PA, Grayson PC.
    Rheumatology (Oxford); 2022 Oct 06; 61(10):4047-4055. PubMed ID: 35022691
    [Abstract] [Full Text] [Related]

  • 43. Does hyperglycemia affect the diagnostic value of 18F-FDG PET/CT?
    Mirpour S, Meteesatien P, Khandani AH.
    Rev Esp Med Nucl Imagen Mol; 2012 Oct 06; 31(2):71-7. PubMed ID: 22088805
    [Abstract] [Full Text] [Related]

  • 44. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL, Xue YL, Song HJ, Luo QY.
    Nucl Med Commun; 2012 Dec 06; 33(12):1232-42. PubMed ID: 23111353
    [Abstract] [Full Text] [Related]

  • 45. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
    Lee DY, Lee CH, Seo MJ, Lee SH, Ryu JS, Lee JJ.
    Ann Nucl Med; 2014 Oct 06; 28(8):789-95. PubMed ID: 24965850
    [Abstract] [Full Text] [Related]

  • 46. A novel model to assess disease activity in Takayasu arteritis based on 18F-FDG-PET/CT: a Chinese cohort study.
    Ma LY, Wu B, Jin XJ, Sun Y, Kong XF, Ji ZF, Chen RY, Cui XM, Shi HC, Jiang LD.
    Rheumatology (Oxford); 2022 Apr 18; 61(SI):SI14-SI22. PubMed ID: 34156465
    [Abstract] [Full Text] [Related]

  • 47. F-18 FDG PET findings of Takayasu arteritis before and after immunosuppressive therapy.
    Iwabu M, Yamamoto Y, Dobashi H, Kameda T, Kittaka K, Nishiyama Y.
    Clin Nucl Med; 2008 Dec 18; 33(12):872-3. PubMed ID: 19033793
    [Abstract] [Full Text] [Related]

  • 48. 18-FDG-PET in assessing disease activity in Takayasu arteritis: a meta-analysis.
    Cheng Y, Lv N, Wang Z, Chen B, Dang A.
    Clin Exp Rheumatol; 2013 Dec 18; 31(1 Suppl 75):S22-7. PubMed ID: 23433014
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [Vasculitis assessment with [18F]FDG positron emission tomography].
    Liozon E, Monteil J, Ly KH, Vidal E.
    Rev Med Interne; 2010 Jun 18; 31(6):417-27. PubMed ID: 20416990
    [Abstract] [Full Text] [Related]

  • 53. Characterization of F-18 Fluorodeoxyglucose PET/CT in Granulomatosis with Polyangiitis.
    Nelson DR, Johnson GB, Cartin-Ceba R, Specks U.
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Jan 18; 32(4):342-52. PubMed ID: 26847102
    [Abstract] [Full Text] [Related]

  • 54. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
    Park JW, Jo MK, Lee HM.
    BJU Int; 2009 Mar 18; 103(5):615-9. PubMed ID: 19007371
    [Abstract] [Full Text] [Related]

  • 55. Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu's and giant cell arteritis using positron emission tomography.
    Soriano A, Pazzola G, Boiardi L, Casali M, Muratore F, Pipitone N, Catanoso M, Aldigeri R, Cimino L, Versari A, Salvarani C.
    Clin Exp Rheumatol; 2018 Mar 18; 36 Suppl 111(2):99-106. PubMed ID: 29799393
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.